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Abstract
Skeletal muscle development involves the differentiation of myoblasts into myotubes;
likely involving connexins (Cx) and the gap junctional exchange of secondary messengers
and metabolites. Many patients with oculodentodigital dysplasia (ODDD), a rare primarily
autosomal dominant disease caused by mutations in the gene encoding Cx43, become less
ambulatory with aging and exhibit symptoms that may reflect defects in skeletal muscle
development, maintenance, and repair. In this study, the role of Cx43 in skeletal muscle
development was examined in differentiation-competent L6 myoblasts and two ODDDlinked Cx43-mutant mouse lines. Undifferentiated L6 myoblasts exhibited high levels of
Cx43-based gap junctions which were inhibited by the co-expression of I DOT and G60S
mutants. Upon myotube formation, Cx43 was down-regulated and gap junctions were lost.
Cx43-mutant mice heterozygous for the I130T mutation exhibited similar body weight and
tibial length as littermate controls while mutant mice heterozygous for the G60S mutation
were significantly smaller and had smaller muscle fibres. Overall, Cx43 regulation may be
important for initial myoblast differentiation but not linked to myotube growth and while our
mutant mouse studies suggest that some ODDD patients are predicted to have smaller muscle
fibres, this appears to be dependent on the site of the Cx43 mutation or other unknown
etiologies.
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CHAPTER ONE:
INTRODUCTION
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1.1 Skeletal Muscle
1.1.1

Skeletal Muscle Fibre Characterization
Skeletal muscle is the most abundant tissue in the vertebrate body. Each muscle in

the body is composed of a variable pattern of contractile fibres. These fibres are
heterogeneous due to the different anatomical, physiological and biochemical demands of
various muscles (Biressi et al., 2007).
Muscle fibres are made up of myofibrils which consist of myofilaments.
Myofilaments are overlapping arrangements of thick myosin and thin actin filaments.
Myosin is composed of heavy and light chains and it is the myosin heavy chain (MyHC)
that is responsible for the powerstroke that causes a muscle contraction (Ross and
Pawlina, 2006). Actively contracting skeletal muscle is the most energy-demanding tissue
in the body and these muscles are required to generate a wide range of forces and
movements (Kelly and Rubenstein, 1994). Animals have adapted to these demands by
developing fast and slow muscle fiber types, which have different contractile properties
and express different MyHC protein isoforms (Schiaffmo et al. 1989). Slow type 1
muscle fibers have a slow contraction velocity and express P-cardiac/slow myosin heavy
chain (MyHC I). Fast type 2 fibers have fast contraction velocities and can be classified
as type 2A, 2B, or 2X fibers expressing MyHC 2A, 2B or 2X (Termin et al, 1989). Each
anatomically distinct muscle has a characteristic pattern of these slow and fast muscle
fiber types.

1.1.2

Skeletal Muscle Fibre Development

Myogenesis is a dynamic process in which undifferentiated myoblasts (committed
precursor muscle cells) withdraw from the cell cycle, differentiate, and finally fuse to
form multinucleated myotubes. In vivo, myotubes mature to form muscle fibres. Almost
all the skeletal muscle in the vertebrate body is derived from progenitors in the somites,
which are mesodermal units on both sides of the neural tube (Christ and Ordahl, 1995).
Each somite differentiates into a dorsal dermomyotome from which the myogenic
precursors originate. The development and growth of muscle is attributed to populations
of muscle progenitor cells (derived from the dermomyotome) present in the embryonic
stage that co-express the transcription factors Pax3 and Pax7 (Biressi et al, 2007). These
progenitors migrate into the limb in three temporally distinct phases as embryonic, fetal
and adult (satellite cell) myoblast lineages (Figure 1.1). Embryonic myoblasts migrate
into the limb in the embryonic phase (E ll) giving rise to primary myotubes, expressing
type 1 MyHC and programmed to the slow lineage. Fetal myoblasts migrate into the limb
during the fetal time period (E14.5-17.5) and fuse together to form secondary myotubes,
which express fast MyHC and are committed to the fast phenotype. Satellite cells, found
in the limb at birth and involved in post-natal muscle growth and as well as muscle fibre
regeneration, differentiate into adult myoblasts (Biressi et al., 2007).
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Fig. 1.1. Proposed lineage in skeletal muscle development.
Myogenic precursor cells, present during embryogenesis, that co-express transcription
factors Pax7 and Pax3 are derived from the somitic dermomyotome. These progenitors
migrate into the limb during embryonic development, fetal development and at birth.
Embryonic and fetal myoblasts give rise to primary and secondary muscle fibres,
respectively. Satellite cells appear at birth and are responsible for post-natal development
and repair o f skeletal muscle. Schematic diagram adapted from Biressi et al., 2007.
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1.2 Satellite Cells
1.2.1 Contribution to Muscle Development
Satellite cells are the precursor cells for the development and repair of adult skeletal
muscle. These cells are undifferentiated mononuclear myogenic cells that lie along the
muscle fibre under the basal lamina (Buckingham et al., 2003). Satellite cells appear at
birth and divide and the majority of them fuse with the adjacent fibre to contribute new
nuclei to the growing fibre. At the end of postnatal growth, these cells enter quiescence
and remain dormant until activated by external cues such as muscle injury or a
myodegenerative disease (Le Grand and Rudnicki, 2007). When activated, these cells
undergo cell division to produce fusion-competent myoblasts which add on to existing
fibres or form new fibres. Unlike embryonic and fetal myoblasts, satellite cells have
plasticity and can generate either slow or fast muscle fibers depending on the needs of the
muscle (Biressi et al., 2007). A fraction of the satellite cell population does not fuse with
the fibre and instead replenishes the satellite cell population (Biressi et al., 2007). This
self-renewal has limited capacity however, so under pathological conditions skeletal
muscle undergoes degeneration. Satellite cells are present in all skeletal muscles but
occur in different distributions.
The percentage of satellite cells in adult slow soleus muscle is two- to three-fold
higher than in adult fast tibialis anterior muscle (Charge & Rudnicki, 2004). There is also
a variation in satellite cell population with age. Evidence suggests a decrease in satellite
cell density over time. At birth, satellite cells contribute 30% of sublaminar muscle nuclei
in mice followed by a decrease to less than 5% in 2-month-old mice (Charge & Rudnicki,
2004).

6

1.2.2

Pax7 and Pax3
Transcription factor Pax7 is expressed by all satellite cells and is critical for their

postnatal maintenance and self-renewal. Studies with Pax7 mutant mice have shown a
decrease in body weight and muscle strength and this decrease progresses with age (Seale
et al., 2000). Pax7 is not expressed at detectable levels in a variety of non-muscle cell
lines or in several adult mouse tissues, therefore it is believed that Pax7 is specifically
expressed only in quiescent satellite cells (Seale et al., 2000). In Pax7 mutant mice,
satellite cell numbers are close to normal at birth but then progressively are lost due to
cell death. Pax7-null skeletal muscle still contains satellite cells but they are functionally
defective (Kuang et al., 2006).
Pax3 is also expressed in satellite cells and can be detected after activation in
most myoblasts. Pax3 is known to be crucial for the migration of muscle progenitor cells
in to the limb but its role in muscle regeneration is not defined because Pax3-null mice
die in utero. Although its role in development and regeneration is unknown, it has been
shown that Pax3 is unable to compensate for a loss of Pax7 suggesting that these two
transcription factors play unique roles in myogenesis (Relaix et al., 2006). Pax3 has also
been shown to be expressed in non-muscle lineages including neural derivatives, but its
muscle-promoting activity is likely negatively regulated in these non-muscle cells
(Goulding et al., 1991).

1.3 Molecular Markers of Skeletal Muscle Fibre Development
At each stage of muscle fibre development, a variety of muscle-specific proteins are
expressed (Figure 1.2). As noted earlier, Pax7 is a marker for quiescent satellite cells. The
activation of satellite cells to cycling myoblasts depends on the expression of Myf5.
These myoblasts also express the muscle marker, MyoD, which is required for their
differentiation. Both Myf5 and MyoD are transcriptional activators of the myogenic
regulatory factor (MRF) family and Myf5:MyoD double knockout mice show a total loss
of skeletal muscle (Charge & Rudnicki, 2004). There is also a down-regulation of Pax7 at
this stage. As these cycling myoblasts leave the cell cycle and differentiate to myocytes,
they lose Pax7 expression and begin to express the differentiation marker myogenin.
Myogenin-deficient mouse embryos die perinatally due to a deficit in myoblast
differentiation (Charge & Rudnicki, 2004). After myocytes fuse into multinucleated
myofibres, myogenin expression remains but there is an additional expression of late
MRFs such as myogenic regulatory factor 4 (MRF4) and myosin heavy chains (MyHCs)
\

(Le Grand and Rudnicki, 2007). Additionally, it is well known that there are no gap
junctions in adult skeletal myofibres however they are present in the earlier stages of
myogenesis involving the development of myoblasts (Balogh et al., 1993).

1.4

Skeletal Myoblast Cell Lines
The two cell lines most commonly used to study skeletal muscle growth and

differentiation are the C2C12 and L6 myoblast lines (Lawson & Purslow, 2000). C2C12
myoblasts are derived from adult mouse skeletal muscle (Yaffe & Saxel, 1977) and
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Figure 1.2. Adult Skeletal Myogenesis
Satellite cells, expressing transcription factor Pax7 become activated by cues from the
external environment such as muscle injury. These cells become cycling myoblasts and
begin to express muscle regulatory factors MyoD and Myf5. Once committed to
differentiation, these myoblasts lose Pax7 and Myf5 expression and become myocytes,
expressing MyoD and myogenin. These myocytes will then fuse with one another and
form multi-nucleated myotubes which express myogenin and MyHC. While connexins
are expressed during the developmental stages of skeletal muscle, there are no connexins
present in fully developed skeletal muscle fibres. Schematic diagram adapted from Le
Grand and Rudnicki, 2007.

represent a satellite cell model, while L6 myoblasts are derived from rat neonatal muscle
(Yaffe, 1968) and exhibit more of a fetal phenotype. For the purpose of this project, L6
myoblasts were chosen over C2C12 myoblasts because of their greater success in being
manipulated and because of their enhanced level of endogenous Cx43.
1.5 Gap Junctions
1.5.1

Gap Junction Function

Gap junctions play an important role in intercellular communication allowing for
cell homeostasis, maintenance, and function (Laird, 2006). Most cells in normal tissues
excluding erythrocytes, adult skeletal muscle cells, and circulating lymphocytes
communicate via gap junctions indicating their pivotal role in human physiology (Dbouk
et al., 2009). Gap junctions consist of clusters of intercellular channels that connect
adjacent cells and allow small molecules o f less than 1 kDa in size to be exchanged
between adjoining cells (Goldberg et al, 1999; Simon & Goodenough, 1998). Some
molecules that are able to pass through gap junctions include adenosine triphosphate
(ATP), cyclic adenosine monophosphate (cAMP), and various ions. The roles of gap
junctions range from the intercellular propagation of electrical signals to the selective
intercellular passage of small regulatory molecules. Within any one cell type there are
many combinations of gap junction proteins that can intermix to make up different gap
junction channels that are each selective in the molecules that they let through resulting in
a wide variety o f cellular functions (Laird, 2006).
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1.5.2

Gap Junction Structure and Synthesis
Connexins are the basic protein subunits of gap junction channels (Figure 1.3A).

A connexin consists of two extracellular loops, a cytoplasmic loop and four
transmembrane domains. Both the amino (N)- and carboxyl (C)-termini are exposed to
the cytoplasm (Laird, 2006). Sequence conservation between the 21 different connexin
family members is highest within the transmembrane domains, the extracellular loops and
the N-terminus (Duffy et al, 2002). In contrast the cytoplasmic loop domain and the Cterminus are variable in length and sequence, and thus account for many of the functional
differences among the connexin family members (Dbouk et al., 2009). The C-terminus of
connexins is thought to play many key regulatory roles as well as contain many binding
sites for other proteins in the establishment of the gap junction proteome (Solan &
Lampe, 2009; and Laird, 2010). Connexin nomenclature is based on the molecular weight
of the protein predicted from the cDNA sequence of the connexin. For example,
connexin43 (Cx43) refers to a connexin with a molecular weight of 43 kDa (Dbouk et al.,
\

2009).
Connexins are highly regulated proteins due to an unusually short half life of only
a few hours compared to other integral membrane proteins (Laird, 2006). This quick
turnover allows connexins to be rapidly synthesized and degraded depending on the
physiological needs of the cell (Laird, 2006). The life cycle of a connexin begins when it
is co-translationally inserted into the endoplasmic reticulum (ER), where it folds into a
stable form. In the case of Cx43, oligomerization is delayed until the Golgi apparatus
(Musil & Goodenough, 1993), while other connexins may oligomerize into hexamers
(known as connexons) while still residents of the ER (Maza et al., 2003) (Figure 1.3B).

Connexons are transported to the cell surface with the aid of microtubules, where they
potentially function as hemichannels, regulating the exchange of molecules between the
cytosol and the extracellular environment (Saez et al., 2005). Once at the cell surface,
connexons diffuse freely within the lipid bilayer to dock with a connexon from another
cell, forming a gap junction channel. Multiple gap junction channels diffuse through the
lipid bilayer, accumulate and cluster together where two cells meet, forming a gapjunction plaque often consisting of hundreds of gap junction channels (Laird, 2006)
(Figure 1.3C).

1.5.3

The Gap Junction Proteome

Connexins associate with and are regulated by a number of proteins. The gap
junction proteome consists of over 40 different proteins including various kinases,
scaffolding and cytoskeletal proteins and trafficking regulators (Laird, 2010). Connexins
are regulated by several kinases, for example, the phosphorylation of Cx43 by protein
kinase A (PKA) increases migration to the cell membrane (Solan & Lampe, 2009).
Scaffolding and cytoskeletal proteins such as zonula occludens-1 (ZO-1) form a protein
network that helps bridge connexins to microfilaments that can further cross-talk with
other molecules (Laird, 2006). Connexins also interact with trafficking regulators such as
caveolin 1, which appears to facilitate connexin assembly and ultimately regulate the
degree of gap junctional intercellular communication (Langlois et al., 2008).
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1.5.4

Connexin Expression

There are 21 known connexin family members in humans and 20 members in
mice leading to their diverse and ubiquitous distribution (Sohl & Willecke, 2004).
Between man and mouse, 19 connexins exist as orthologous pairs. The expression of
connexins within the human body depends on the cell or the tissue type being studied and
many of these cells and tissues express more than one type of connexin. For example, the
liver expresses both Cx26 and Cx32, and kératinocytes express at least Cx26, Cx30,
Cx30.3, Cx31, Cx31.1 and Cx43 (Laird, 2006). Cx43 is the most ubiquitous member of
the connexin family and is expressed in over 35 different cell and tissue types including
developing myoblasts (Laird, 2006; Balogh et al., 1993). The fact that certain cells or
tissues can express more than one connexin means that different types of gap junction
channels can exist. Channel diversity arises from different connexins oligomerizing into
different connexons. A connexon may be homomeric in that it consists of only one type
of connexin (eg. Cx43) or it can be heteromeric in that it is formed from two or more
connexins (eg. Cx43 and Cx45) (Martinez et al., 2002). Additionally, gap junction
channels can consist of two connexons made from the same connexin (homotypic) or
more than one type of connexin (heterotypic) (Figure 1.3D). The complexity of these
combinations results in large variability in the types of gap junction channels that can be
assembled (Laird, 2006). It is possible that one type of connexin can influence the effects
of another connexin found in the same connexon or gap junction channel. Furthermore,
co-expression of many connexin members within the same cell allows for possible
compensatory mechanisms to overcome the loss or mutation of one connexin family
member (Laird, 2006).

Connexin

iimum

Connexon

mmm
iinmm
uuum

c
Homomeric
Homotypic

D

I II
Heteromeric
Homotypic

Homomeric
Heterotypic

Figure 1.3. The Structure of Gap Junctions

Gap junctions are composed of connexins that exhibit a topology consisting of 2
extracellular loops, a cytoplasmic loop, four transmembrane domains, and a cytoplasmic
N- and C-terminus (A). Six connexins oligomerize into a protein hexamer known as a
connexon, which can be heteromeric or homomeric (B, D). Connexons dock with
connexons from an opposing cell forming a heterotypic or homotypic gap junction
channel (C, D).

1.5.5

Gap Junctions in Skeletal Muscle

Connexins are not present in adult skeletal muscle fibres; however connexin
expression has been reported in developing myoblasts (Dahl et al., 1995; Araya et ah,
2005; Maltzahn et ah, 2004). Interestingly, connexin expression appears to be limited to
the embryonic phase of muscle development (Dalh et ah, 1995; Maltzahn et ah, 2004).
Cx40 has been found to be transiently expressed in skeletal muscle of mouse embryos
(Dahl et ah, 1995) but has not been found in adult mice (Araya et ah, 2005). Cx39 has
been shown to be expressed in embryonic mice but not expressed after birth (Maltzahn et
ah, 2004). Araya et al (2005) showed an increase in Cx43 and Cx45 in regenerating adult
mouse skeletal muscle but they proposed that only Cx43 played a role in muscle
regeneration and repair. This current study found no Cx45 in adult mouse skeletal
myoblasts and therefore concluded that Cx43 is the only connexin playing a significant
role in adult skeletal muscle remodeling.

\

1.6

Connexin 43

1.6.1

Cx43 Protein Structure and Properties
The human GJA1 gene encodes the gap junction protein alpha 1 which is

routinely referred to as Cx43. This gene is localized to chromosome 6 at the locus 6q22q23 and is composed of two exons with an intervening 11 bp intron in between (Paznekas
et ah, 2003) however the entire coding region for Cx43 is encoded on exon 2. There is
also a GJA1 pseudogene (GJA1P1) located within human chromosome 5 at the 5q215q22 locus. This pseudogene of Cx43 is distinct from the actual Cx43 gene in that it lacks
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the intervening intron (Willecke et al., 1990). As with nearly all genes encoding
connexins the genetic structure of the Cx43 gene consists of: an untranslated exon 1
separated by an intron from exon 2 which contains the uninterrupted coding region, and
the 3’-untranslated region (3’-UTR) (Willecke et al., 2002).
The Cx43 protein consists of 382 amino acid residues and has a relatively long Cterminal tail (150 residues) compared to other connexin proteins such as Cx32 (Figure
1.4) (Beyer et al, 1987). The C-terminal tail is not highly ordered but does contain at least
one alpha helix (Sorgen et al., 2002). The C-terminal tail is thought to be responsible for
many of the key regulatory functions of the protein and is the location for most proteinprotein interactions (Giepmans & Moolenaar, 1998). The essential role of the C-terminal
is highlighted by the fact that mice engineered to lack the C-terminus of Cx43 die shortly
after birth (Maass et al., 2004). Furthermore, the C-terminal tail has been implicated in
the regulation of channel gating, and unlike other connexin family members, has been
shown to bind directly to tubulin (Giepmans et al, 2001). This has lead to the possibility
that along with its role as a channel forming protein, Cx43 may also be involved as a
microtubule-anchoring protein.
Less is known about the role of the N-terminus of Cx43 but amino acids in the Nterminus have been shown to be crucial for Cx43 channel function and are involved in
the oligomerization compatibility of different connexin proteins (Lagree et al., 2003).
Also, the majority of Cx43 mutations causing oculodentodigital dysplasia occur in the Nterminal two-thirds of the Cx43 protein (Laird 2008) and are noticeably rare in the Cterminal domain.
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Figure 1.4. Topology of Connexin43

Cx43 consists of four transmembrane domains, two extracellular loops (EL), a
cytoplasmic loop (CL), and intracellular amino (NLL) and carboxyl (COOH) termini.
Cx43 is characterized by a long C-terminal tail consisting of approximately 150 amino
acids. Figure adapted from Laird, 2008.

Cx43 transport, gating, assembly, degradation and other aspects of the life cycle
all appear to be regulated by post-translational modifications such as phosphorylation.
The C-terminal of Cx43 is the prime target for phosphorylation and this phosphorylation
is induced by the activation of many kinases such as protein kinase A (PKA), protein
kinase C (PKC) and mitogen-activated protein kinase (MAPK) (Solan & Lamp, 2009).
Cx43 is differentially phosphorylated and SDS-PAGE analysis has revealed multiple
electrophoretic isoforms including a fast, minimally-phosphorylated form (P0) and two
slower migrating forms called PI and P2 (Solan & Lampe, 2009). The PI isoform is
found predominantly in the plasma membrane and the P2 isoform is found exclusively in
gap junctions (Solan et al., 2007 and Lampe et al., 2006). Activation of PKA can increase
Cx43 movement to the plasma membrane and several mutations in which specific serines
are converted to alanines result in little or no ability of Cx43 to form gap junctions
(Cooper and Lampe, 2002). Furthermore, Cx43 dramatically changes its phosphorylation
status throughout its life cycle as part of homeostasis as well as in response to stimuli
(Lampe and Lau, 2004).

1,6.2

Cx43 Expression and Function in Myoblasts

Cx43 is not expressed in adult skeletal muscle but is present in developing
myoblasts. This expression is down-regulated once fusion is initiated to form myotubes
(Balogh et al, 1993). Previous studies on L6 myoblasts using non-specific gap-junctional
blockers such as heptanol (Mege et al., 1994) as well as 1-octanol and P-glycyrrhetinic
acid (Proulx et al., 1997, Araya et al., 2003) have been used to inhibit myoblast fusion.
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These studies revealed that a decrease in gap junctional intercellular communication
(GJIC) leads to a reduction in myoblast fusion and the mRNA expression of myogenic
markers (Proulx et al., 1997). While the compounds used in these studies are non-specific
blockers and are almost certainly blocking other channels (eg. pannexins), they do
suggest that GJIC plays a significant role in myogenic differentiation in vitro.
It has been shown that Cx43 is present in C2C12 myoblasts (Constantin &
Cronier, 2000) and that its expression is up-regulated during muscle regeneration in vivo
and in primary cells (Araya et al., 2005). Araya et al. 2005 assessed the regeneration of
the mouse tibialis anterior (TA) muscle after BaCl2-induced injury. In this study the
authors found that 5 days after injury, there was a maximum expression of myogenin as
well as Cx43. Later, myogenin and Cx43 levels returned to a similar level as that found in
uninjured cells (Araya et al., 2005). This same group also showed that in primary mouse
myoblasts an absence in Cx43 expression led to reduced myogenin and MyoD protein
expression as well as reduced differentiation as assessed by creatine kinase activity.
These results indicate that Cx43 may be necessary for the differentiation of myoblasts as
well as the repair of skeletal muscle after injury.
In another study, it has also been reported that an increase in Cx43 results in
increased L6 myoblast differentiation into myotubes (Suzuki et al., 2001). Suzuki et al
(2001) also found that L6 cells over-expressing Cx43 showed enhanced intercellular
communication and enhanced differentiation compared to wild type L6 myoblasts.
Finally, skeletal muscle-specific conditional Cx43 knock-out mice exhibited a delay in
myotube formation and prolonged expression of myogenin during muscle regeneration in
vivo (Araya et al, 2005). All these studies suggest that Cx43-based gap junctions likely
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play an important role in the regeneration and differentiation of adult skeletal muscle yet
the effects of various disease-linked mutant connexins on muscle development both at the
cellular and animal level remain unknown.

1.7

Connexin-Linked Diseases

1.7.1

Overview
Connexin mutations are linked to many human diseases. Over 270 mutations in

the gene encoding Cx32 have been linked to Charcot-Marie-Tooth Disease, which results
in demyelination of peripheral axons (Krutovskikh & Yamasaki, 2000; and Kleopa &
Scherer, 2006). Mutations in Cx47 are linked to Pelizaeus-Merzbacher-like disease that
also results in defective myelination (Bugiani et al., 2006). Mutations in at least five
different connexin family members (Cx26, Cx30, Cx30.3, Cx31 and Cx43) are
responsible for deafness with mutations in Cx26 alone accounting for 35-45% of all
neurosensory hearing loss (Laird 2008). Many of the mutations in the connexin genes that
cause deafness have also been linked to skin diseases such as Vohwinkel’s syndrome and
palmoplantar keratodermas (Laird, 2006). Furthermore, there are numerous autosomal
dominant and two autosomal recessive mutations in the gene that encodes Cx43 that
result in a disorder known as oculodentodigital dysplasia (Laird, 2008).

1.7.2

Oculodentodigital Dysplasia

Oculodentodigital dysplasia (ODDD) is a rare autosomal dominant disorder
caused by mutations in the GJA1 gene that encodes Cx43 (Laird 2006). Over 60
mutations in the Cx43 gene have been linked to ODDD (Figure 1.5) and the majority of
them are dominant missense mutations (Paznekas et al., 2009). Patients with ODDD
exhibit common symptoms such as developmental defects in the craniofacial bones
around the eyes and nose, syndactyly of the digits, skin disorders, and dental problems
such as loss of enamel, however there is a wide spectrum of phenotypes associated with
the disease (Laird 2006). It has also been shown that some patients exhibit anterior tibial
muscle weakness (Paznekas et al., 2009) as well as general muscle weakness
(Loddenkemper et al, 2002) resulting in less ambulatory control with age. This suggests a
possible link of Cx43 to muscle regeneration and maintenance.

1.7.3

Cx43 Mutants in ODDD

Cx43 is the most universal connexin in the human body yet ODDD patients
harbouring Cx43 mutations are not as affected as one might expect. It seems as though
most ODDD patients are able to live long lives in relatively good health (Laird 2006).
ODDD-linked Cx43 mutants have been assessed and shown to exhibit one of two
subcellular localization profiles. First, most mutants are able to reach the cell surface and
assemble into gap junctions indicating no problems in trafficking. These mutants, such as
I130T, are either unable to form functional gap junction channels or they do so poorly in
comparison to wild type Cx43. The second group includes mutants such as fs260 that are
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Figure 1.5. Composite of Cx43 Mutations Associated with ODDD.

Over 60 mutations in the GJA1 gene are associated with oculodentodigital dysplasia. The
majority of these mutations are autosomal dominant missense mutations. There are also
two known autosomal recessive mutations and two autosomal dominant frame-shift
mutations (updated from Laird 2006).
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unable to traffic to the cell surface and tend to accumulate in the Golgi apparatus (Laird
2008).
It has been shown that when mutant and wild type Cx43 species are co-expressed
they can intermix resulting in the mutant acting as a dominant-negative to the function of
wild type Cx43 (Gong et ah, 2007; Roscoe et al., 2005; Shibayama et al., 2005).
Furthermore, different mutants exhibit different potencies in their ability to act as a
dominant negative (Gong et ah, 2007). The fact that patients with Cx43 mutations are
able to live relatively healthy lives may be due to a number of possibilities that include:
humans express more Cx43 than needed, the residual activity of wild type Cx43 is able to
sustain sufficient GJIC (Shibayama et ah, 2005), or other compensatory mechanisms
exist to sustain sufficient GJIC (Laird, 2006).

1.7.4

Mouse Models of ODDD

Several Cx43 disease-linked mutant mice have been generated to study the role of
Cx43 in ODDD, two of which are the focus of this study. One mutant mouse line,
G jalJrt/\ (also called G60S mice) harbors a G60S point mutation (Flenniken et ah, 2005).
This autosomal dominant gene mutation responsible for the G60S mutation has not been
found in patients but these mice show similar morphological abnormalities as human
ODDD patients, such as syndactyly of the digits and craniofacial abnormalities. The
G60S mutation is located in the first extracellular loop and this mutant has a partial
trafficking defect and poor channel forming properties (Roscoe et ah, 2005). These mice
have been shown to have a reduction in total Cx43 protein, GJIC, and in the number of
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gap junction plaques, indicating that the mutant is indeed dominant to co-expressed wild
type Cx43 (Flenniken et al., 2005). The second mouse line, Gjal""J(,/' (otherwise referred
to as the I130T mouse) harbors an I130T mutation (Kalcheva et al., 2007) which is an
autosomal dominant gene mutation found in the human ODDD population. These mice
also mimic the symptoms of human patients and show a reduction in total Cx43 protein.
I130T mutant mice do not exhibit the heart abnormalities seen in the G60S mutant mouse
such as atrial septic defect and ventricular tachycardia (Kalcheva et al., 2007) suggesting
that each mouse may have unique phenotypes. G60S mutant mice are visibly smaller than
their wild type counterparts while I130T mutant mice show no difference in size
(Flenniken et al., 2005). Not only do both of these mice mimic the disease state in the
human population but both mutants show different disease-linked phenotypes mimicking
the range o f symptoms found in human ODDD patients.

1.8

Rationale, Hypothesis and Objectives

1.8.1

Rationale

Cx43 and gap junctions have been shown to possibly play an important role in L6
myoblast differentiation as well as mouse muscle regeneration (Proulx et al., 1997; Araya
et al., 2003, 2005; and Suzuki et al., 2001). Mutations in the GJA1 gene expressing Cx43
lead to ODDD and it has been documented that some ODDD patients suffer from a loss
of ambulatory control, general muscle weakness and specific weakness of the tibialis
anterior muscle. In the current study we propose that there is a relationship between
germ-line mutations in Cx43 that cause loss of Cx43-based gap junction function and the
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ability of skeletal muscle to develop normally. To that end, I first examined the regulation
of Cx43 during myoblast differentiation into myotubes and assessed the effect of Cx43
mutant expression on Cx43 function in myoblasts. Furthermore, I studied two mutant
mouse models of ODDD focusing on differences in skeletal muscle fibre size in relation
to body weight and tibial length. These studies included both the soleus and tibialis
anterior muscles since they offer a comparison between muscles expressing mainly slow
fibres versus fast fibers, respectively.

1.8.2

Hypothesis

Cx43-mediated gap junctional intercellular communication is necessary for
normal skeletal myoblast differentiation and loss-of-function disease-linked I130T and
G60S Cx43 mutants will impair this process.

1.8.3. Objectives

Objective 1: To characterize Cx43 in undifferentiated and differentiated L6 myoblasts
and determine if I130T and G60S Cx43 mutants inhibit GJIC.

Objective 2: To determine soleus and tibialis anterior muscle fibre areas in 3-week-old
and 3-month-old wild type and I130T and G60S Cx43 mutant mice that mimic ODDD.

25

1.9 References

Araya, R., D. Eckhart, M.A. Riquelme, K. Willecke and J.C. Saez. 2003. Presence and
importance of connexin43 during myogenesis. Cell Commun. and Adhesion. 10: 451-456.
Araya, R., D. Eckhart, S. Maxeiner, O. Kruger, M. Theis, K. Willecke, and J.C. Saez. 2005.
Expression o f connexins during differentiation and regeneration o f skeletal muscle:
functional relevance of connexin43. J. Cell Sci. 118: 27-37.

Balogh, S., C.C.G. Naus, and P.A. Merrifield. 1993. Expression of gap junctions in
cultured rat L6 cells during myogenesis. Developmental Biol. 155(2): 351-360.
Berthoud, V.M., E.A. Montegna, N. Atal, N.H. Aithal, P.R. Brink, and E.C. Beyer. 2001.
Heteromeric connexons formed by the lens connexins, connexin43 and connexin56.
Europ. J. o f Cell Biol. 80(1): 11-19.
Beyer, E.C., D.L. Paul, and D.A. Goodenough. 1987. Connexin43: a protein from rat
heart homogenate to a gap junction protein from liver. Journal Cell Biol. 105(6):
2621-2629.
Beyer, E.C., J. Gemel, K.H. Seul, D.M. Larson, K. Banach, and P.R. Brink. 2000.
Modulation of intercellular communication by differential regulation and
heteromeric mixing of co-expressed connexins. Braz. J. Med. Biol. Res. 33(4): 391397.
Biressi, S., M. Molinaro, and G. Cossu. 2007. Cellular heterogeneity during vertebral
skeletal muscle development. Developmental Biol. 308: 281-293.
Buckingham, M., L. Bajard, T. Chang, P. Daubas, J. Hadchouel, S. Meilhac, D.
Montarras, D. Rocancourt, and F. Relaix. 2003. The formation of skeletal muscle:
from somite to limb. J. o f Anatomy. 202(1): 59-68.
Bugiani, M., S. A1 Shahwan, E. Lamantea, A. Bizzi, E. Bakhsh, I. Moroni, M.R.
Balestrini, G. Uziel, and M. Zeviani. 2006. GJA12 mutations in children with
recessive hypomyelinating leukoencephalopathy. Neurology. 67(2): 273-279.
Charge, S.B.P., and M.A. Rudnicki. 2004. Cellular and molecular regulation of muscle
regeneration. Physiological Review. 84(1): 209-238.
Christ, B., and C.P. Ordahl. 1995. Early stages of chick somite development. Anatomy
and Embryology. 191(5): 381-396.

Constantin, B., and L. Cronier. 2000. Involvement of gap junctional communication in
myogenesis. International Review o f Cytology. 196: 1-65.
Cooper, C.D., and P.D. Lampe. 2002. Casein kinase 1 regulates connexin43 gap junction
assembly. J. Biol. Chem. 277: 44962-44968.
Dahl, E., E. Winterhager, O. Traub, and K. Willecke. 1995. Expression of gap junction
genes, connexin40 and connexin43, during fetal mouse development. Anal, and
Embryol. 3: 267-278.
Dbouk, H.A., R.M. Mroue, M.E. El-Sabban, and R.S. Talhouk. 2009. Connexins: A
myriad o f functions extending beyond assembly of gap junction channels. Cell
Communication and Signalling. 7: 4.
Desplantez, T., D. Halliday, E. Dupont, and R. Weingart. 2004. Cardiac connexins Cx43
and Cx45: formation of diverse gap junction channels with diverse electrical
properties. Eur. J. Physiol. 488: 363-375.
Duffy, H.S., M. Delmar, and D.C. Spray. 2002. Formation of the gao junction nexus:
binding partners for connexins. J. o f Physiology - Paris. 96(3): 243-249.
Flenniken, A.M., L.R. Osborne, N. Anderson, N. Ciliberti, C. Fleming, J.E. Gittens, X.
Gong, L.B. Kelsey, C. Lounsbury, L. Moreno, B.J. Nieman, K. Peterson, D. Qu,
Roscoe, Q. Shao, D. Tong, G.I. Veitch, I Voronina, I. Vukobradovic, G.A. Wood,
Y. Zhu, R.A. Zimgibl, J.E. Aubin, D. Bai, B.G. Bruneau, M. Grynpas, J.E.
Henderson, R.M. Henkelman, C. McKerlie, J.G. Sled, W.L. Stanford, D.W. Laird,
G.M. Kidder, S.L. Adamson, and J. Rossant. 2005. A Gjal missense mutation in a
mouse model of oculodentodigital dysplasia. Development. 132(19): 4375-4386.
Giepmans, B.N.G., and W.H. Moolenaar. 1998. The gap junction protein connxin-43
interacts with the second PDZ domain of the zonula occludens-1 protein. Current
Biology. 8: 931-934.
Giepmans, B.N.G., I. Verlaan, T. Hengeveld, H. Janssen, J. Calafat, M.M. Falk, and
W.H. Moolenaar. 2001. Gap junction protein connexin-43 interacts directly with
microtubules. Current Biology. 11: 1364-1368.
Goldberg, G.S., P.D. Lampe, and B.J. Nicholson. 1999. Selective transfer of endogenous
metabolites through gap junctions composed of different connexins. Nature Cell
Biol. 1: 457-459.

27

Goliger, J.A., and D.L. Paul. 1994. Expression of gap junction proteins Cx26, Cx31.1,
Cx37 and Cx43 in developing and mature rat epidermis. Developmental Dynamics.
200(1): 1-13.
Gong, X.Q., Q. Shao, S. Langlois, D. Bai, and D.W. Laird. 2007. Differential potency of
dominant negative connexin43 mutants in Oculodentodigital dysplasia. J. Biol.
Chem. 282: 19190-19202.
Goulding, M.D., G. Chalepakis, U. Deutsch, J.R. Erselius, and P. Gruss. 1991. Pax-3, a
novel murine DNA binding protein expressed during early neurogenesis. Embo. J.
10(5): 1135-1147.
He D.S., J.X. Jiang, S.M. Taffet, and J.M. Burt. 1999. Formation of heteromeric gao
junction channels by connexins 40 and 43 in vascular smooth muscle cells. Proc.
Natl. Acad. Sci. 96: 6495-6500.
Kalcheva, N., Q. Jiaxiang, N. Sandeep, L. Garcia, J. Zhang, Z. Wang, P.D. Lampe, S.O.
Suadicani, D.C. Spray, and G.I. Fishman. 2007. Gap junction remodeling and
cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia. Proc.
Natl. Acad. Sci. 104(51): 20512-20516.
Kelly, M.A., and N.A. Rubinstein. The diversity of muscle fiber types and its origin
during development. Engel AG Franzini-Armstrong C eds. Myology. 1994; 119133. McGraw Hill New York.
Kleopa, K.A., and S.S. Scherer. 2006. Molecular genetics of X-linked Charcot-MarieTooth disease. NeuroMolecular Medicine. 8: 107-122.
Krutovskikh, V., and H. Yamasaki. 2000. Connexin gene mutations in human genetic
diseases. Mutation Research. 462: 197-207.
Kuang, S., S.B. Charge, P. Seale, M. Huh, and M.A. Rudnicki. 2006. Distinct roles for
Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 172(1): 103-113.
Lagree, V., K. Brunschwig, P. Lopez, N.B. Gilula, G. Richard, and M.M. Falk. 2003.
Specific amino-acid residues in the N-terminus and TM3 implicated in channel
function and oligomerization compatibility of connexin43. J. Cell Sci. 116: 31893201.
Laird, D.W. 2006. Life cycle of connexins in health and disease. Biochem. J. 394: 527543.

28

Laird, D.W. 2008. Closing the gap on autosomal dominant connexin-26 and connexin-43
mutants linked to human disease. J. Biol. Chem. 282: 2997-3001.
Laird, D.W. 2010. The gap junction proteome and its relationship to disease. Trends in
Cell Biology. 20(2): 92-101.
Lampe, P.D., and A.F. Lau. 2004. The effects of connexin phosphorylation on gap
junctional communication. Int. J. ofBiochem. Cell Biol. 36: 1171-1186.
Lampe, P.D., C.D. Cooper, T.J. King, and J.M. Burt. 2006. Analysis of Connexin43
phosphorylated at S325, S238 and S330 in normoxic and ischemic heart. J. Cell
Sci. 119: 3435-3442.
Langlois, S., K.N. Cowan, Q. Shao, B.J. Cowan, and D.W. Laird. 2008. Caveolin-1 and 2 interact with connexin43 and regulate gap junctional intercellular communication
in keratinocytes. Molec. Biol, o f the Cell. 19: 912-928.
Lawson, M.A., and P.P. Purslow. 2000. Differentiation of myoblasts in serum-free
media: effects of modified media are cell line-specific. Cells Tissues Organs.
167(2): 130-137.
Le Grand, F., and M.A. Rudnicki. 2007. Skeletal muscle satellite cells and adult
myogenesis. Current Opinion in Cell Biology. 19: 628-633.
Loddenkemper, T., K. Grote, S. Evers, M. Oelerich and F. Stogbauer. 2002. Neurological
manifestations of the Oculodentodigital dysplasia syndrome. J. Neurol. 249: 584596.
\
Maltzahn J., C. Euwens, K. Willecke, and G. Sohl. 2004. The novel mouse connexin39
gene is expressed in developing striated muscle fibres. J. Cell Sci. 117: 5381-5392.
Martinez, A.D., V. Hayrapetyan, A.P. Moreno, and E.C. Beyer. 2002. Connexin43 and
connexin45 form heteromeric gap junction channels in which individual
components determine permeability and regulation. Circ. Res. 90: 1100-1107.
Maass, K., A. Ghanem, J.S. Kim, M. Saathoff, S. Urschel, G. Kirfel, R. Grummer, M.
Kretz, T. Lewalter, K. Tiemann, E. Winterhagen, V. Herzog, and K. Willecke.
2004. Defective epidermal barrier in neonatal mice lacking the C-terminal region of
concexin43. Mol. Biol. Cell. 15: 4597-4608.
Maza, J., M. Mateescu, J.D. Sarnia, and M. Koval. 2003. Differential oligomerization of
endoplasmic reticulum-retained connexin43/connexin32 chimeras. Cell Commun.
Adhes. 10: 319-322.

29

Mege, R.M., D. Goudou, C. Giaume, M. Nicolet, and F. Reiger. 1994. Is intercellular
communication via gap junctions required for myoblast fusion? Cell Commun. and
Adhesion. 2(4): 329-343.
Musil, L.S., and D.A. Goodenough. 1993. Multisubunit assembly of an integral plasma
membrane channel protein, gap junction connexin43, occurs after exit from the ER.
Cell. 74: 1065-1077.
Paznekas, W.A., S.A. Boyadjiev, R.E. Shapiro, O. Daniels, B. Wollnik, C.E. Keegan,
J.W. Innis, M.B. Dinulos, C. Christian, M.C. Hannibal, and E.W. Jabs. 2003.
Connexin43 (GJA1) mutations cause the pleiotropic phenotype of
Oculodentodigital dysplasia. Amer. J. Human Genetics. 72(2): 408-418.
Paznekas, W.A., B. Karczeski, S. Vermeer, R.B. Lowry, M. Delatycki, F. Laurence, P.A.
Koivisto, L.V. Maldergem, S.A. Boyadjiev, J.N. Bodurtha, and E.W. Jabs. 2009.
GJAI mutations, variants, and connexin43 dysfunction as it relates to the
Oculodentodigital dysplasia phenotype. Human Mutation. 30(5): 724-733.
Proulx, A., P. Merrifield, and C.C.G. Naus. 1997. Blocking gap junctional intercellular
communication in myoblasts inhibits myogenin and MRF4 expression. Develop.
Genetics. 20: 133-144.
Relaix, F., D. Montarras, S. Zaffran, B. Gayraud-Morel, D. Rocancourt, S. Tajbakhsh, A.
Mansouri, A. Cumano, and M. Buckingham. 2006. Pax3 and Pax7 have distinct and
overlapping functions in adult muscle progenitor cells. J. o f Cell Biol. 172(1): 91102.
Roscoe, W., G.I.L Veitch, X.G. Gong, E. Pellegrino, D. Bai, E. McLachlan, Q. Shao,
G.M. Kidder, and D.W. Laird. 2005. Oculodentodigital dysplasia-causing
connexin43 mutants are non-functional and exhibit dominant effects on wild-type
connexin43. J. o f Biological Chemistry. 280(12): 11458-11466.
Ross, M.H., and M.D. Pawlina. 2006. Histology: A Text and Atlas 5th Edition. Lippincott
Williams & Wilkins. Baltimore, MD. 280-288.
Schiaffmo, S., L. Gorza, S. Sartore, L. Saggin, S. Ausoni, M. Vianello, K. Gundersen and
T. Lomo. 1989. Three myosin heavy chain isomers in type 2 skeletal muscle fibres.
J. o f Muscle Research and Cell Motility. 10(3): 197-205.
Saez, J.C., M.A. Retamal, D. Basilio, F.F. Bukauskas, and M.V. Bennett. 2005.
Connexin-based gap junction hemichannels: gating mechanisms. Biochim. Biophys.
Acta. 1711(2): 215-224.

30

Seale, P., L.A. Sabourin, A. Girgis-Gabardo, A. Manouri, P. Gruss, and M.A. Rudnicki.
2000. Pax7 is required for the specification of myogenic satellite cells. Cell. 102(6):
777-786.
Shibayama, J., W. Paznekas, A. Seki, S. Taffet, E.W. Jabs, M. Delmar, and H. Musa.
2005. Functional characterization o f connexin43 mutations found in patients with
Oculodentodigital dysplasia. Circul. Research. 96: 83-91.
Simon, A.M., and D.A. Goodenough. 1998. Diverse functions of vertebrate gap
junctions. Trends in Cell Biology. 8(12): 477-483.
Simon, A.M., H. Chen, and C.L. Jackson. 2006. Cx37 and Cx43 localize to zona
pellucida in mouse ovarian follicles. Cell Commun. Adhes. 13(1): 61-77.
Sohl, G., and K. Willecke. 2004. Gap junctions and the connexin protein family.
Cardiovasc. Research. 62: 228-232.
Solan, J.L., L. Marquez-Rosado, P.L. Sorgen, P.J. Thornton, P.R. Gafken, and P.D.
Lampe. 2007. Phosphorylation of Cx43 at S365 is a gatekeeper event that changes
the structure of Cx43and prevents downregulation by PKC. J. Cell Biol. 179: 13011309.
Solan, J.L., and P.D. Lampe. 2009. Connexin43 phosphorylation - Structural changes
and biological effects. Biochem. J. 419(2): 261-272.
Sorgen, P.L., H.S. Duffy, S.M. Cahill, W. Coombs, D.C. Spray, M. Delmar, and M.E.
Girvin. 2002. Sequence-specific resonance assignment of the carboxyl terminal
domain of connexin43. J. Biomol. NMR. 23: 245-246.
Suzuki, K., N.J. Brand, S. Allen, M.A. Kahn, A.O. Farrell, B. Murtuza, R.E. Oakely, and
M.H. Yacoub. 2001. Overexpression of connexin43 in skeletal myoblasts:
relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. 122: 759-766.
Termin, A., R.S. Staron, and D. Pette. 1989. Myosin heavy chain isoforms in
histochemically defined fibre types of rat muscle. Histochemistry and Cell Biology.
92(6): 453-457.
Willecke, K., S. Jungbluth, E. Dahl, H. Hennemann, R. Heynkes, and K.H. Grzeschik.
1990. Six genes of the human connexin gene family coding for gap junctional
proteins are assigned to four different human chromosomes. Europ. J. Cell Biol.
53(2): 275-280.

31

Willecke, K., J. Eiberger, J. Degen, D. Eckhart, A. Romualdi, M. Guldenagel, U.
Deutsch, and G. Sohl. 2002. Structural and functional diversity of connexin genes
in the mouse and human genome. Biol. Chem. 383(5): 725-737.
Yaffe, D. 1968. Retention of differentiation potentialities during prolonged cultivation of
myogenic cells. Proc. Natl. Acad. Sci. 61: 477-483.
Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells
isolated from dystrophic mouse muscle. Nature. 270: 725-727.

\

32

CHAPTER TWO:
The Effect of Connexin43 on the Development of Skeletal Muscle Using Cell and
Animal Models of Oculodentodigital Dysplasia
Pasquale Vecchio1
'Department of Anatomy and Cell Biology, Faculty of Medicine and Dentistry,
The University of Western Ontario, London, Ontario, Canada
N6A5C1

33

2.1 Introduction
Skeletal muscle is composed of multinucleated muscle fibres which can be
classified as fast or slow fibre types based upon physiological properties and the
expression of myosin heavy chain (MyHC) isoforms (Schiaffino et al., 1989). Each
anatomically distinct muscle has a characteristic pattern of muscle fibre types. During
myogenesis, muscle fibres are derived from undifferentiated myoblasts which withdraw
from the cell cycle, activate muscle-specific contractile protein synthesis, and fuse to
form multinucleated myotubes. In the adult, fusion-competent myoblasts originate from
the activation of muscle satellite cells, which first appear around birth and reside beneath
the basal laminae of mature muscle fibres. These satellite cells serve as precursor cells for
the postnatal development and repair of adult skeletal muscle (Buckingham et al., 2003).
Different muscle-specific proteins are expressed at each stage of myogenesis.
Pax7 is a marker for quiescent satellite cells which are activated to become cycling
myoblasts following muscle injury. These myoblasts express the muscle markers Myf5
and MyoD which are required for their subsequent differentiation. As these cycling
myoblasts leave the cell cycle and differentiate to form myocytes, they lose Pax7
expression, initiate myogenin expression and accumulate muscle-specific contractile
proteins such as myosin, actin, tropomyosin and troponin (Le Grand and Rudnicki, 2007).
Myocytes fuse into multinucleated myotubes which mature in vivo to form specific
muscle fibre types which express different MyHCs (Le Grand and Rudnicki, 2007).
Myogenesis can be studied in primary cultures of myoblasts and in established
myoblast cell lines, such as L6 myoblasts, which were originally derived from neonatal
rat muscle (Yaffe, 1968). We have previously shown that L6 myoblasts express
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connexin43 (Cx43), form functional gap junctions, and down-regulate Cx43 expression
as they differentiate into myotubes in vitro (Balogh et al., 1993).
Gap junctions play an important role in intercellular communication allowing for
cell homeostasis, maintenance, and function (Laird, 2006). Gap junctions consist of
clusters of intercellular channels that connect adjacent cells and allow small molecules of
less than 1 kDa in size to be exchanged between adjoining cells (Goldberg et al, 1999;
Simon & Goodenough, 1998).
Connexins are the basic protein subunits of gap junction channels. Connexins are
encoded by a multi-gene family and there are 21 different members in the human
population. Connexins oligomerize into connexons prior to being transported to the cell
surface where they potentially function as hemichannels, regulating the exchange of
molecules between the cytosol and the extracellular environment (Saez et al., 2005).
However, connexons quickly dock with connexons from a contacting cell to form gap
junction channels that proceed to cluster into a mature and fully assembled gap junction
(Laird, 2006).
Connexins are not present in adult skeletal muscle fibres; however Cx43, Cx45,
and Cx39 have all been reported in developing myoblasts (Dahl et al., 1995; and
Maltzahn et al., 2003). Araya et al (2005) showed that Cx43 and Cx45 increased in
injured adult mouse skeletal muscle but they concluded that only Cx43 seemed to play a
role in muscle regeneration.
Studies using non-specific gap-junctional blockers (Mege et al., 1994; Proulx et
al., 1997, and Araya et al., 2003) have been used to inhibit myoblast fusion and the
expression of myogenic markers suggestive of a role for gap junctions in early stages of
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myogenesis. Further, transgenic mouse studies where Cx43 was specifically ablated from
skeletal muscle myoblasts revealed a delay in myoblast differentiation and in myotube
formation (Araya et al., 2005). It has also been reported that an increase in Cx43 results
in increased L6 myoblast differentiation into myotubes (Suzuki et al 2001). All these
studies suggest that a full complement of Cx43 may be critical for normal muscle
development raising the question as to whether patients with compromised Cx43 function
may have deficiencies in muscle development, maintenance, or repair.
Oculodentodigital dysplasia (ODDD) is a rare primarily autosomal dominant
disorder caused by mutations in the GJAl gene that encodes Cx43 (Laird 2006). Patients
with ODDD exhibit common symptoms such as craniofacial abnormalities, syndactyly of
the digits, skin disorders, and dental problems such as loss of enamel. However there are
other more rare symptoms associated with this disease (Laird 2006). Specifically, it has
also been shown that some patients exhibit anterior tibial muscle weakness (Paznekas et
al., 2009) as well as general muscle weakness (Loddenkemper et al, 2002) resulting in
less ambulatory control with age, raising a possibility that at least some of these patients
may have compromised skeletal muscle function due to reduced Cx43 function.
Importantly it has been well established that disease-linked Cx43 mutants have dominant
negative effects on co-expressed wild type Cx43, firmly establishing that it is likely that
ODDD patients have severely impaired overall Cx43 function (Gong et al., 2007; Roscoe
et al., 2005; and Shibayama et al., 2005).
Cx43 disease-linked mutant mouse lines have been generated that mimic ODDD
and are extremely useful to investigate the role of Cx43 in various tissues and organs.
One mutant mouse (G jalJr,/+) line harbors a G60S missense mutation in the first
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extracellular loop of the Cx43 protein (Flenniken et al., 2005). A second mouse line
harbors an I130T mutation in the cytoplasmic loop of the Cx43 protein (Kalcheva et al.,
2005). Not only do these mice mimic ODDD, but both mutants also show different
disease-linked phenotypes mimicking the range of symptoms found in human patients.
In the present study we investigated the regulation of Cx43 expression and
localization in both undifferentiated and differentiated L6 myoblasts and determined the
effect of co-expression of ODDD-linked Cx43 mutants on GJIC. In parallel in vivo
studies we characterized skeletal muscle development in young and aging ODDD-linked
mutant mice. Collectively, our combined in vitro and in vivo studies revealed that Cx43
is exquisitely regulated during myoblast differentiation and only some ODDD-linked
mutants may impair myoblast differentiation into fully mature fibres.

2.2

Methods

2.2.1

Cell Culture
The L6 myoblast cell line was obtained from American Type Culture Collection

(Manassas, VA, USA). L6 myoblasts were maintained in a growth medium consisting of
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Burlington, ON, Canada) with
4,500 mg/L D-glucose, and supplemented with 10% fetal bovine serum (FBS,
Invitrogen), 2 mM L-glutamine (Invitrogen) and 100 pg/ml penicillin and 100 pg/ml
streptomycin (Invitrogen). For cell passage, cells were washed with Hanks Buffered Salt
Solution (HBSS, Sigma-Aldrich, St. Louis, MO, USA), treated with 0.25% TrypsinEDTA (Invitrogen) and incubated for 4-5 minutes in 37°C until cells were detached from
the flasks. The appropriate volume of growth medium was added to re-suspend the cells
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and they were kept in a 25 ml flask containing fresh medium which was changed every
two days.

2.2.2

Cell Transfections
L6 cells were transfected using a Nucleofector Kit specific for myoblasts from

Lonza (Cologne, Germany). The transfection protocol according to the manufacturer’s
recommendations is as follows: L6 cells were grown in culture and then collected and
centrifuged, followed by re-suspension in growth medium. Cell numbers were counted as
follows: 10 pi of cell-containing medium were added to 10 pi of Trypan Blue
(Invitrogen) and loaded into a 50 cell counting chamber slide (Invitrogen) and analyzed
using Countess Automated Cell Counter (Invitrogen). Cells were diluted as necessary to
obtain 1 x 106 cells per milliliter. Two ml of sample were added to a tube, centrifuged
(IEC Centra CL2 Centrifuge, Thermo Scientific, Rockford, IL, USA) and the supernatant
discarded. Cells were re-suspended with 100 pi of cell line nucleofector solution plus
supplements (Lonza) as well as 2 pg of pmaxGFP DNA (provided by Lonza)
representing a positive control. The sample was transferred to a nucleofector tube
(Lonza) and inserted into a Nucleofector II apparatus (Lonza). After nucleofection, cells
were collected using a sterile pipette and added to 6 ml of growth medium. Cells were
mixed well and transferred to 3 wells of a 6-well plate containing 2 ml of growth medium
and 2 coverslips in each well. GFP expression was analyzed by a Leica DM IRE2
inverted epifluorescent microscope (Richmond Hill, ON, Canada). This procedure was
also performed with cDNAs encoding Cx43-GFP as well as the I130T-GFP and G60SGFP mutants.
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2.2.3

Generation of GFP-tagged Constructs
Constructs containing cDNA for human Cx43-green fluorescent protein (Cx43-

GFP) and G60S-GFP were generated previously (Roscoe et al., 2005, and McLachlan et
al., 2008, respectively). The I130T-GFP-tagged construct was purchased from Norclone
Biotech Industries, London, ON, Canada and the DNA sequence was verified to confirm
the isoleucine to threonine mutation at amino acid 130 of human Cx43.

2.2.4

Differentiation Assay
Wild type L6 cells as well as L6 myoblasts expressing various GFP-tagged

constructs were each plated in a 60 mm dish containing three coverslips and kept in
growth medium until they reached 80% confluence. Next, one coverslip was removed
and fixed in 80% methanol/20% acetone solution (representing day 0 of differentiation)
and stored in phosphate buffered saline (PBS) at 4°C while differentiation medium was
added to the dish containing the other two coverslips. Differentiation medium was
composed of alpha-Modified Eagle Medium (a-MEM, Invitrogen) with low glucose, and
supplemented with 2% horse serum (Wisent Inc., St. Bruno, QC, Canada) and 0.5 ml
Gentamicin (Invitrogen). Medium was changed every two days. Each subsequent
coverslip was fixed and stored in PBS at 4°C at days 3 and 6 in the differentiation
medium. Cx43 and MyHC expression was analyzed by immunocytochemistry using a
Zeiss LSM 510 META confocal microscope (Thomwood, NY, USA). For the
differentiation assay, the number of MyHC-positive myocytes or myotubes in the field
was counted as well as the number of nuclei per myotube.
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2.2.5

Phase Contrast Imaging
L6 cells were plated in three 60 mm dishes and were cultured in growth medium

until 80% confluence. At this point, one dish was selected for imaging while the other
two were switched to differentiation medium. Phase contrast images of the selected dish
were taken using a Leica DMIL Inverted Contrasting Microscope with a DFC340 FX
Digital Colour Camera. Images were visualized using the Leica Application Suite V3
imaging software. At day 3 and day 6 of differentiation respectively, images were taken
of the remaining two dishes.

2.2.6

Immunocytochemistry
L6 cells were plated on coverslips, switched to differentiation medium, and

collected and fixed on days 0, 3, and 6 and as described previously. Coverslips were
aspirated and incubated in 2% bovine serum albumin (BSA)/ PBS blocking mixture
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA) for 40 minutes at room temperature.
Coverslips were then aspirated and washed three times in PBS. Coverslips were
incubated overnight at 4°C in the following primary antibodies: rabbit anti-Cx43 (SigmaAldrich; C 6219) 1:500; mouse monoclonal anti-MF20 IgG (Developmental Studies
Hybridoma Bank, Iowa City, IA, USA; supernatant) 1:200; mouse anti-F5D IgG (DSHB;
supernatant) 1:10; and mouse anti-GM130 (BD Biosciences, Missisauga ON, CA;
610822) 1:500. Coverslips were washed and incubated for one hour at room temperature
in the following secondary antibodies: AlexaFluor® anti-mouse 555 IgG (Invitrogen;
A21427) 1:500; AlexaFluor® anti-rabbit 488 IgG (Invitrogen; A11008) 1:500 and
AlexaFluor® anti-rabbit 555 IgG (Invitrogen; A21428) 1:500. Coverslips were washed
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and nuclei were stained using Hoechst dye 33342 (Molecular Probes, Eugene, OR, USA;
H I399) for 5 minutes followed by one wash in PBS and one wash in double distilled
water (ddH20). Coverslips were mounted on glass Colorfrost microscope slides (Fisher
Scientific, Pittsburg, PA).
Fluorescently labeled cells were imaged on a Zeiss LSM 510 META confocal
microscope at 40X optical zoom. AlexaFluor® 488 fluorescence was excited using a 488
nm argon laser line, and emissions were captured using a 500-550 nm band pass filter.
AlexaFluor® 555 fluorescence was excited with a 543 nm helium-neon laser line, with
emissions collected using a 600-655 nm band pass filter.

2.2.7

Western Blot Analysis
L6 cells were plated in three 60 mm dishes and cultured in growth medium until

80% confluence. Once cells reached confluency, two dishes were switched to
differentiation medium while protein was collected from the remaining dish (representing
day 0 o f differentiation). Cells in the dish were collected in a tube of PBS with a cell
scraper. Samples were centrifuged and re-suspended in a lysis buffer consisting o f single
detergent lysis buffer (50 mM Tris-Cl, 150 mM NaCl, and 1% TritonX-100) mixed with
protease inhibitor (Roche Diagnostics, Indianapolis, IN, USA), 50 mM NaF and 0.5 mM
NaV 0 4 . Cell lysates were stored in -20°C. Protein was collected from the other two
dishes after day 3 and 6 of differentiation.
Cell lysates were sonicated using a 60 Sonic Dismembrator (Fisher Scientific) for
2 seconds each and then centrifuged at 9,800 rpm for 1.5 minutes. The supernatant was
removed and used for western blotting. Protein concentration was measured using the
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BCA Protein Assay Kit (Thermo Scientific). Thirty pg of protein was electrophoresed on
10% polyacrylamide gels and transferred to a nitrocellulose membrane using the iBlot gel
transfer kit (Invitrogen) for 9 minutes. The membrane was blocked for 40 minutes in 5%
milk buffer (2.5 g milk powder (Santa Cruz) in 0.05% Tween-20 in PBS). The membrane
was then incubated overnight at 4°C with the following primary antibodies: rabbit antiCx43 (Sigma-Aldrich; C 6219), 1:5000; mouse anti-MF20 IgG (DSHB; supernatant)
1:200; and mouse anti-(3-tubulin (Abeam; ab6046) 1:2000. Membranes were washed with
0.05% Tween-20 in PBS and then incubated for one hour at room temperature with the
following secondary antibodies: AlexaFluor® rabbit 680 (Invitrogen, A21076) and
AlexaFluor® mouse 800 (Rockland, Gilbertsville, PA, USA; 610-132-121) 1:10,000
dilution. Membranes were rinsed and developed using the Odyssey infrared fluorescence
imaging system (Li-Cor Biosciences). Protein expression was quantified with Odyssey
3.0 software (Li-Cor) by densitometric analysis. Protein levels were normalized to Ptubulin (loading control).
\

2.2.8

Microinjection

L6 cells were grown in dishes until 80% confluent. One cell within a cell cluster was
pressure microinjected with 5% Lucifer yellow (Molecular Probes, Leiden, Netherlands)
until the cell was brightly fluorescent using an Eppendorf FemtoJet automated pressure
microinjector. After 1 minute, the percentage of microinjected cells that transferred
Lucifer yellow to at least one contacting cell was determined using a Leica DM IRE2
inverted epifluorescent microscope. Digital images were collected with a charged
coupled device camera (Hamamatsu Photonics, Japan) using OpenLab software
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(Improvision). At least 20 microinjections were performed for each experimental
condition.

2.2.9

Disease-Linked Mutant Mice
All animal experiments were approved by the Animal Use Subcommittee of the

University Council on Animal Care at the University of Western Ontario. The G60S mice
were generated at the Centre for Modeling Human Disease, University of Toronto, ON,
and were provided by Dr. Janet Rossant. The mice were originally on a mixed C57BL/6J
and C3H/HeJ background (Flenniken et al., 2005). After confirming 100% penetrance of
the oligosyndactyly feature of the mutant phenotype by PCR genotyping (Flenniken et
al., 2005), genotypes were ascertained by visual inspection of pups. The mice were
maintained under a constant photoperiod of 12 h light:dark cycle and received food and
water ad libitum. The I130T mice were generated and provided by Glenn Fishman from
the New York University Medical Center, NY. In the case of the I130T mice, sitedirected mutagenic clones were inserted into C57BL/6J blastocysts and these mice were
II ? f)T
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crossed with wild type CD1 females to generate the FI Gjal UJU,/+ population (Kalcheva
et al., 2007). The mutant mice were further back crossed onto C57BL/6J background
mice for 1-3 generations. Both I DOT and G60S mice along with their littermate controls
were collected at 3 weeks and 3 months of age.
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2.2.10 Mouse Tissue Dissection
All mice were sacrificed using CO 2 and O2 . After body weight measurements,
tibialis anterior and soleus muscles were dissected from both hind limbs of mutant mice
and their wild type littermates and stored in -80°C. Tibial bone length was also measured
for each control and mutant mouse.

2.2.11 Paraffin Embedding and Sectioning
Frozen muscle tissue to be used for immunostaining and hematoxylin and eosin
(H&E) staining were thawed and fixed in 10% formaldehyde overnight. Samples were
then switched to PBS and embedded in melted paraffin wax in a cross-sectional
orientation and cooled into plastic blocks (Robarts Research Institute, London, ON,
Canada). Samples were cut into 10 pm sections using a Leica RM 2125RT microtome
and placed on slides and left overnight at 40°C. Samples were stored in 4°C until needed.

2.2.12 H&E Staining and Muscle Cross-section Assay Measurements

Wild type and mutant muscle sections were deparaffmized and rehydrated by
incubating in: xylene for 9 minutes, 100% ethanol for 9 minutes, 95% ethanol for 3
minutes, 70% ethanol for 3 minutes and deionized water for 5 minutes. Samples were
stained with 1% hematoxylin for 1.5 minutes followed by a rinse in distilled water.
Samples were incubated in tap water for 5 minutes and then dipped 8-12 times in acid
ethanol followed by 2 minutes in tap water. Slides were placed in 1% eosin stain for 1.5
minutes followed by: 95% ethanol for 9 minutes, and 100% ethanol for 9 minutes.
Samples were left in xylene overnight and then covered with coverslips using Cytoseal
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(Canadawide Scientific, Ottawa, ON, Canada) and glass micro covers (VWR). Muscle
cross-sections were visualized and images were taken using a Zeiss Axioplan2IE
microscope and analyzed using AxioVision Rel. 4.3 software. Muscle cross-section areas
and diameters were measured using ImageJ software. Measurements were normalized to
the scale of 11.8 pixels/pm.

2.2.13 Statistical Analysis
For the western blot analysis, results were analyzed using a one-way ANOVA
with a Tukey’s Post Hoc test. In all other cases, results were analyzed using a Student’s
two-tailed independent sample T-test for significance using a value of p<0.05. All
statistical analysis was performed using Microsoft Excel software and GraphPad Prism
4.0 Software Inc. Graphs represent mean ± standard error of the mean.
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2.3 Results

2.3.1

Cx43 is primarily localized to gap junction-like plaques at the cell surface in

L6 myoblasts.

To examine the localization profile of Cx43 in undifferentiated myoblasts,
immunofluorescent co-localization was performed using a rabbit antibody against Cx43
and a mouse monoclonal antibody against a Golgi resident protein GM130. In
undifferentiated L6 myoblasts, Cx43 was localized to sites of cell-cell contact (Figure
2.1 A, see arrows) as well as occasionally at intracellular sites near the nuclei. Co
localization studies for Cx43 and the resident Golgi protein GM130 revealed that
occasionally Cx43 was detected in the proximity of the Golgi apparatus (Figure 2.1B,C).

2.3.2 Muscle differentiation markers MyHC and myogenin are up-regulated and
Cx43 is down-regulated in differentiated L6 myoblasts.
L6 myoblasts cultured in differentiation medium were able to form myotubes
(Figure 2.2A-F). After 3 days in differentiation medium, the onset of L6 cell
differentiation was evident as demonstrated by the presence of multinucleated myotubes
(Figure 2.2B) while at 6 days, myotubes appear to increase in length (Figure 2.2C). After
9 days o f differentiation, not only did the number of myotubes and their lengths look
similar to that at 6 days, but also cells began to die (data not shown).

Figure 2.1. Cx43 is localized to gap junction-like plaques at the cell surface and the
Golgi apparatus in L6 myoblasts.

Cx43 (green) was localized to punctate structures between adjacent
undifferentiated L6 cells (A, arrows; C) and to GM 130-positive (red) perinuclear
structures indicative of the Golgi apparatus (B, C). Nuclei were stained with Hoechst dye.
Bar = 20 pm.
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To further examine the extent of cell differentiation and the fate of Cx43, both
undifferentiated and differentiated L6 myoblasts were assessed for the expression of
MyHC and Cx43. After 3 and 6 days of differentiation, myotubes were detected based on
the cytoplasmic expression of MyHC (red; Figure 2.2E,F). Furthermore, Cx43 expression
(green) appeared to be lost in cells that expressed MyHC (Figure 2.2E,F). Similarly,
Cx43 expression was less evident in cells that expressed myogenin (Figure 2.2G, H, I).
Western blots revealed an increase in MyHC expression and a reduction in Cx43 levels in
L6 cell cultures induced to differentiate (Figure 2.3). Quantitative analysis shows a
significant increase in MyHC protein expression and a significant decrease in Cx43
expression after 6 days of differentiation (Figure 2.3C, and D, respectively). These data
revealed that L6 myoblasts differentiate well under induced differentiation conditions and
this corresponded with a loss of Cx43 expression.

2.3.3 L6 myoblasts differentiating into myotubes peaks at 3 days but myotubes
continue to grow in size.

The differentiation of L6 myoblasts into MyHC-positive myocytes or myotubes
peaks after 3 days of differentiation (Figure 2.4A). However, there is a significant
increase in the number of nuclei per MyHC-positive myotubes up to six days of
differentiation (Figure 2.4B). This suggests that L6 myoblasts reach a point of maximum
myotube formation, after which pre-existing myotubes increase in size after fusing with
differentiating myoblasts.

Figure 2.2. L6 myoblasts differentiate into MyHC- and myogenin-positive but
Cx43-negative myotubes.

Differentiated myoblasts fuse into myotubes after culturing for 3 and 6 days in
differentiation medium (A-C). Bar = 80 pm. After 3 (B, E, H, I) and 6 days (C, F),
differentiated myotubes expressed MyHC (D-F; red) or the nuclear protein myogenin (GI; red) but do not express Cx43 (D-I; green). Undifferentiated myoblasts do not express
MyHC or myogenin (D, G). Hoechst dye was used to stain nuclei. Bar = 20 pm.

Figure 2.3. MyHC is upreguiated in differentiated myoblasts while Cx43 is downregulated.

Western blot analysis reveals an increase in MyHC expression (A; 220 kDa) and a
reduction in Cx43 (B; doublet at 43 kDa) in L6 cell cultures induced to differentiate. Ptubulin at ~50 kDa was used as a loading control. Quantification of these results revealed
a significant increase in MyHC protein expression (N=4) and a significant decrease in
Cx43 expression (N=5) after 6 days of differentiation (C, D; respectively). P < 0.05.
Error bars represent means +/- standard error (with ‘a’, ‘b \ and ‘c’ significantly different
from each other).
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2.3.4

L6 cells expressing Cx43 mutant proteins exhibit reduced dye coupling
compared to wild type L6 myoblasts.
Undifferentiated wild type L6 myoblasts express Cx43 which was localized to

sites of cell-cell contacts (Figure 2.5A). All Cx43 mutants were able to traffic to the cell
surface and assemble into gap junction-like plaques when expressed in undifferentiated
L6 myoblasts (Figure 2.5E, I, M). In parallel, Cx43 mutant-expressing myoblasts were
assessed for the ability to transfer microinjected dye to contacting neighboring cells
(Figure 2.5). While the instances of undifferentiated wild type L6 myoblasts or cells
over-expressing Cx43 transferring microinjected dye to one or more contacting cells was
extremely high, the instances of microinjected G60S and I130T mutant-expressing cells
transferring dye was significantly reduced (Figure 2.5). These results suggest that
disease-linked Cx43 mutants can impair Cx43-based GJIC in myoblasts.

2.3.5

G60S Cx43-mutant mice are smaller but have similar tibial lengths
compared to their wild type controls.
I130T mutant mice did not demonstrate a significant difference in body weight

compared to their wild type littermates at either 3 weeks or 3 months of age (Figure
2.6A). G60S mutant mice were significantly smaller than their wild type littermates at
both time points (Figure 2.6B). At 3 weeks and 3 months of age (solid and striped
columns, respectively), I130T (Figure 2.6C) and G60S mutant mice (Figure 2.6D) had
tibia lengths similar to that of their wild type littermates. This was a surprising finding as
overall the G60S mice have less body weight but it appears the leg bones are similar in
length.

Figure 2.4. L6 myoblast differentiation into myotubes peaks at 3 days but myotubes
continue to grow in size.

L6 myoblast differentiation into MyHC-positive myocytes and myotubes peaks
after 3 days (A). However, the number of Hoechst-dye-labeled nuclei per myotube
continues to significantly increase at 6 days (B). N=3, n=20. P < 0.05. Error bars
represent means +/- standard error (with ‘a’, ‘b \ and ‘c’ significantly different from each
other).
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Figure 2.5 L6 cells expressing Cx43 mutant proteins exhibit reduced dye coupling
compared to wild type L6 myoblasts.

Undifferentiated wild type (Wt) L6 myoblasts express Cx43 (green) at sites of
cell-cell appositions (A). Myoblasts were successfully engineered to express GFP-tagged
wt and Cx43 mutants as evidenced by the presence of GFP fluorescence (E, I, M; green).
Nuclei were labeled with Hoechst dye. Parallel populations of cells were microinjected
with Lucifer yellow dye and the incidence of dye transfer to one or more contacting cells
was quantified (Q). Representative fluorescent images were captured before injection (B,
F, J, N), and after injection (C, G, K, O). Phase contrast images (D, H, L, P) and asterisks
denote the microinjected cells. N=20. P < 0.05. Error bars represent means +/- standard
error (with ‘a’ and ‘b’ significantly different from one another).
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2.3.6

G60S mutant mice have smaller muscle fibres than their wild type littermate

controls while I130T mutant mice show no significant difference.

Based on visual histological analysis the I130T mutant mouse soleus muscle
fibres do not appear to be significantly different in muscle fibre area compared to wild
type littermate controls (Figure 2.7A-D) and this result was confirmed by quantification
of muscle fibre areas (Figure 2.71). Likewise, the I130T mutant mouse TA muscle fibres
exhibited some visual evidence that they may be smaller than wild type littermate control
mouse fibers (Figure 2.7E-H), however quantification of these images revealed no
significant difference (Figure 2.7J). In the case of the G60S mutant mice, histological
images of both the soleus and TA muscle fibres revealed that the fibres were smaller
compared to wild type littermate controls (Figure 2.8A-H) and this result was confirmed
by quantification of muscle fibre area (Figure 2.81, J).

Figure 2.6 G60S Cx43-mutant mice are smaller but have similar tibial lengths as
littermate controls while I130T Cx43-mutant mice have similar body
weights and tibial lengths as littermate controls.

I130T mutant mice did not differ in body weight compared to their wild type
littermates at either 3 weeks (solid columns) or 3 months of age (striped columns; A).
G60S mutant mice were significantly smaller than their wild type littermates at both 3
weeks (solid columns) and 3 months of age (striped columns; B). N=4. At 3 weeks (solid
columns) and 3 months of age (striped columns), both I130T (C) and G60S mutant mice
(D) had similar length tibias as their wild type littermates (N=5). P < 0.05. Error bars
represent means +/- standard error (with ‘a’, ‘b ’, ‘c \ and ‘d’ significantly different from
each other).
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Figure 2.7 I130T mutant mice have similar sized muscle fibres compared to their
wild type littermates.

Histological images of soleus muscle from 3-week-old (A,B) and 3-month-old
(C,D) I130T mutant mice (B,D) and their littermate controls (A,C). Note that there is no
difference in muscle fibre area compared to wild type littermate controls (I). Histological
images of tibialis anterior muscle fibres from 3-week- (E, F) and 3-month-old (G, H)
I130T mutant mice (F, H) and their littermate controls (E, G) revealed a potential
difference in muscle fibre area but this was not found to be significant (J). Solid and
striped columns represent 3-week- and 3-month-old mice, respectively. N = 5. Error bars
represent means +/- standard error.
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Figure 2.8 G60S mutant mice have smaller muscle fibres than their wild type
littermates

Histological images of soleus (A-D) and tibialis anterior (E-H) muscle fibres from
3-week- (A, B, E, F) and 3-month-old (C, D, G, H) G60S mutant mice (B, D, F, H) and
their littermate controls (A, C, E, G) revealed a significant difference in muscle fibre area
in the soleus (I) and tibialis anterior (J). Solid and striped columns represent 3-week- and
3-month-old mice, respectively. N = 5.

P < 0.05. Error bars represent means +/-

standard error (with ‘a’ and ‘b’ significantly different from each other).
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2.4 Discussion

2.4.1 The regulation and localization of Cx43 during L6 myoblast differentiation
into myotubes.

It has been shown that Cx43-based gap junctions play a significant role in skeletal
muscle development and repair (Araya et al., 2005; Suzuki et al., 2001) and it is
suggested that gap junctional intercellular communication (GJIC) is an important factor
in these processes (Proulx et al., 1997). Within the last decade it became apparent that
loss-of-function, germ-line mutations in the gene encoding Cx43 leads to a
developmental disorder known as oculodentodigital dysplasia (ODDD) raising the
fundamental question as to whether these patients may have compromised skeletal
muscle development (Flenniken et al., 2005; Roscoe et al., 2005; Paznekas et al., 2003).
In the current study I hypothesized that there is a relationship between disease-linked
Cx43 mutations that cause loss of Cx43-based gap junction function and the normal
development and maintenance of skeletal muscle.
The first objective of my study was to elucidate the localization of Cx43 in
undifferentiated and differentiated L6 myoblasts and to assess if the co-expression of
disease-linked Cx43 mutants would impair GJIC in myoblasts. We found that Cx43
assembled into classical gap junctions in undifferentiated L6 myoblasts with a residual
store of Cx43 within the Golgi apparatus. This pattern of Cx43 localization was similar to
that previously described in other studies of undifferentiated L6 myoblasts (Balogh et al.,
1993; Suzuki et al., 2001). Interestingly, as myoblasts differentiated into myotubes Cx43
expression was lost. Myotube formation was confirmed by the up-regulation o f myosin
heavy chain (MyHC) and the myogenic regulatory factor myogenin which are two key
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molecular markers of myoblast differentiation (Buckingham et ah, 2003; Le Grand and
Rudnicki, 2007). These changes in Cx43 and muscle differentiation marker protein
expression parallels previous studies done by Balogh et al. (1993) and Proulx et ah
(1997), who showed a down-regulation o f Cx43 mRNA during L6 myotube formation.
Typically, myoblasts withdraw from the cell cycle, differentiate, and fuse into
multinucleated elongated myotubes (Biressi et ah, 1997). In this study, significant
myotube formation was observed after three days of induced L6 myoblast differentiation
and myotube growth continued up to six days of differentiation. While MyHC expression
was significantly up-regulated after three days of differentiation, the down-regulation of
Cx43 expression was not evident until day six of differentiation. The down-regulation of
Cx43 in differentiating myoblast cell lines has been proposed to be caused by the upregulation of the microRNA miR-206 (Anderson et ah, 2006). miR-206 is thought to bind
to the 3’ UTR of Cx43 and acts to post-transcriptionally inhibit Cx43 expression. It is
possible that in L6 myoblasts, miR-206 up-regulation does not occur until later in the
differentiation process, explaining the delay in Cx43 down-regulation compared to the
onset of MyHC expression. This proposed mechanism is strengthened by a study by
Gorbe et ah (2005) where Cx43 expression was up-regulated in aligned interacting
myoblasts and was not down-regulated until the actual fusion event.
During adult muscle growth, satellite cells become activated and develop into
myoblasts which eventually fuse with pre-existing myotubes or fuse with one another to
form new myotubes (Bischoff and Heintz, 1994; Charge and Rudnicki, 2004). The
population of myoblasts that fuse with pre-existing myotubes to generate multinucleated
myotubes remains largely uncharacterized (Iezzi et ah, 2004). It is important to note that
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L6 myoblasts have been shown to represent more of a fetal myoblast model compared to
a satellite cell model (Pin and Merrifield, 1997). In both models, myoblasts fuse with one
another as well as with pre-existing myotubes but the mechanisms, factors, and responses
to signaling can differ (Hutcheson et al., 2009). In the current study I examined whether
cycling L6 myoblasts continuously fuse with each other to form new myotubes or if they
eventually only fuse onto pre-existing myotubes. I found that there was a significant
increase in the number of nuclei per myotube at six days of differentiation compared to
that at three days o f differentiation. These findings suggest that L6 cycling myoblasts
reach a point of maximum myotube formation and begin to fuse with pre-existing
myotubes, increasing the number of nuclei per myotube and therefore increasing overall
myotube size. It is possible that Cx43 is required for the initial stages of muscle
differentiation but is not involved in the process of myotube growth. An up-regulation of
Cx43 in myoblasts has been shown to occur simultaneously with a down-regulation of
the proliferation associated Ki67 protein before fusion suggesting a possible role of Cx43
in the process of cell cycle exit of myoblasts (Gorbe et al., 2005). After the cessation of
proliferation, the combined up-regulation of MyHC and myogenin with miR-206 may
result in down-regulation of Cx43 during myotube formation. The fact that myotube
growth continues after the number of myotubes has reached a maximum suggests that
myotube growth is independent of Cx43 expression within the myotube itself.
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2.4.2

The effect of disease-linked Cx43-mutants on gap junctional intercellular
communication between L6 myoblasts.

Patients with ODDD harbor Cx43 mutations that have been shown to have
dominant-negative effects on co-expressed wild type Cx43 suggesting that it is likely that
patients have severely impaired Cx43 function (Gong et al., 2007; Roscoe et ah, 2005;
Shibayama et ah, 2005). In this study, my goal was to mimic the Cx43 status seen in
ODDD patients in L6 myoblasts. I proposed that the expression of disease-linked Cx43
mutants I130T and G60S would render L6 myoblasts gap junctional intercellular
communication (GJIC)-impaired. Lucifer yellow dye transfer in L6 myoblasts expressing
G60S-GFP and I130T-GFP was significantly reduced compared to wild type L6
myoblasts and L6 cells over-expressing Cx43. These findings are in keeping with mutantinduced inhibition of GJIC in primary granulosa cells and osteoblasts from G60S mice
(Flenniken et ah, 2006; McLachlan et ah, 2008; respectively) and in cardiomyocytes
obtained from both I130T and G60S mutant mice (Kalcheva et ah, 2007; Manias et ah,
2008; repsectively). Collectively these studies strongly suggest that the G60S and I130T
Cx43-mutants have a dominant-negative effect on co-expressed Cx43 independent of the
cell type being examined.
However, the mechanisms by which the G60S and I DOT mutants impair Cx43based GJIC in fact may be different. The G60S mutation occurs in the first extracellular
loop and is thought to impede the formation of functional intercellular channels by
interfering with the ability of one connexon to dock with a connexon from an adjacent
cell (Flenniken et ah, 2005). Expression o f the G60S mutant in Cx43-harboring cells
results in a general reduction in total Cx43 protein and in a loss of the highly
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phosphorylated species of Cx43, which typically reflects a reduction in gap junction
plaques (Flenniken et al., 2005; McLachlan et al., 2008; Paznekas et ah, 2009). On the
other hand, the I130T mutation occurs in the cytoplasmic loop of the Cx43 protein and
results in the reduction of the phosphorylated PI and P2 isoforms of Cx43 (Kalcheva et
al, 2007). While both I130T and G60S Cx43 mutants are able to form gap junction-like
plaques when co-expressed with wild type Cx43, the G60S mutant appears very
inefficient in this process and is often found localized to the Golgi apparatus (Flenniken
et ah, 2005; Manias et ah, 2008; McLachlan et ah, 2008; Shibayama et ah, 2005; Tong et
ah, 2009).

2.4.3

Characterization of skeletal muscle in I130T and G60S Cx43-mutant mice
that mimic ODDD.
I have established that disease-linked Cx43 mutants have a dominant negative

effect on L6 myoblast GJIC. It is possible that a loss of communication in myoblasts may
result in impaired muscle development, maintenance and repair. Some ODDD patients
exhibit muscle weakness and loss of ambulatory control with age (Paznekas et ah, 2009;
Loddenkemper et ah, 2002) and this may be caused by the fact that they have greatly
reduced overall Cx43 intercellular channel function. In order to determine if there is a
relationship between loss-of-function Cx43 mutants and impaired skeletal muscle
development, I studied the skeletal muscle status in two Cx43-mutant mouse lines that
mimic ODDD patients. Consistent with past observations (Flenniken et ah, 2005; and
Plante et ah, 2010a), I found that G60S Cx43-mutant mice had significantly less body
weight compared to their littermate controls. These mice differed considerably from
I130T Cx43-mutants which were the same size as littermate controls. From these findings
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I predicted that the G60S mice would also have a smaller bone skeleton but surprisingly,
upon measuring the tibial bone lengths no differences were found.
While some ODDD patients have shown general muscle weakness as well as
specific weakness of the tibialis anterior (TA) muscle (Loddenkemper et al, 2002; &
Paznekas et al., 2009) there is very little information about their skeletal muscle status. I
hypothesized that one or both of the Cx43 mutant mouse lines used in this study would
have a defect in muscle development resulting in smaller muscle fibres than wild type
mice. While the TA muscle in the I130T mutant mouse exhibited hints that they were
smaller than littermate controls this was statistically not the case. However the G60S
Cx43-mutant mouse exhibited significantly smaller muscle fibres in both the TA and
soleus muscle. This was an interesting finding as the percentage of satellite cells in the
soleus muscle is 2-3 fold times higher than in the TA muscle (Charge & Rudnicki, 2004).
Since satellite cells are responsible for adult skeletal muscle growth and repair, it is
possible that a Cx43 mutation does not have as much of an effect on muscles with a
higher population of satellite cells. Alternatively, since the TA muscle has a higher
proportion of fast muscle fibres than the soleus muscle, this trend may be the result of an
increased sensitivity of fast fibres to Cx43 mutations compared to slow muscle fibres.
The difference in muscle fibre size in G60S mice could be the result of impaired muscle
fibre development in the developing embryo or during postnatal development.
Alternatively, it could be a result of impaired muscle repair in response to muscle injury
although we have no evidence that G60S mice underwent any muscle stress or injury.
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Summary:

In this study, the dominant-negative effect of G60S and I130T mutants on co
expressed wild type Cx43 in L6 myoblasts provides support to the notion that ODDD
patients likely have severely compromised Cx43 function in developing and
differentiating myoblasts that could potentially lead to impaired skeletal muscle function,
maintenance and repair. This concept is supported by the fact that G60S mutant mice that
genetically and phenotypically mimic ODDD patients have smaller muscle fibres in both
predominantly fast and slow muscle groups. However, since no muscle fibre differences
were found in the I130T mutant mice, that also mimic ODDD, it is equally possible that
ODDD patients may exhibit some defect in skeletal muscle function due to other
compromising mechanisms. Further studies are necessary to determine if Cx43 mutant
mice suffer from reduced muscle strength or compromised muscle repair after injury.
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CHAPTER THREE:
GENERAL DISCUSSION AND FUTURE PERSPECTIVES
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3.1

Summary and Conclusions

Objective One: Characterize Cx43 in undifferentiated and differentiated L6 myoblasts
and determine ifI130T and G60S Cx43 mutants inhibit GJIC in vitro.

Cx43 has been shown to play an important role in myoblast differentiation
(Suzuki et al., 2001 & Araya et ah, 2005) however the effect that Cx43 point mutations
may have on muscle development has yet to be examined. In this study, I characterized
the regulation and localization of Cx43 in undifferentiated and differentiated L6
myoblasts and investigated the effects of the over-expression of wild type Cx43 and
Cx43-mutants G60S and I130T on the ability of myoblasts to communicate via gap
junctional intercellular communication (GJIC). Cx43 was initially expressed in
undifferentiated L6 myoblasts in plaques at sites of cell-to-cell appositions, with some
Cx43 associated within the Golgi apparatus. Cx43 expression was down-regulated as
cells differentiated into myotubes and there was a concomitant up-regulation of MyHC.
During differentiation, L6 myoblasts originally fuse with each other to form myotubes
but this process was short-lived as later myoblasts appear to fuse only with pre-existing
myotubes, increasing their size. Over-expression of disease-linked Cx43 mutants (while
not impeding the ability of Cx43 to reach the cell membrane) led to significantly reduced
GJIC. The ability of the Cx43 mutants to act as dominant-negatives to wild type Cx43
and impede gap junction function led to the overarching hypothesis that oculodentodigital
dysplasia (ODDD) patients, predicted to have severely compromised Cx43 function, may
exhibit impaired muscle development, maintenance and repair.
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Objective Two: Determine soleus and tibialis anterior muscle fibre areas in 3-week-old
and 3-month-old wild type and I103T and G60S Cx43 mutant mice that mimic ODDD.

Although ODDD patients expressing Cx43 mutations have been shown to develop
muscle weakness (Loddenkemper et al, 2002; & Paznekas et al., 2009), the direct effects
of Cx43 mutations on muscle-related phenotypes have yet to be shown. In this study, I
examined two mouse models of ODDD, focusing on differences in muscle fibre size in
relationship to body weight and tibial length. I130T Cx43-mutant mice showed no
difference in body weight compared to their wild type littermate controls while G60S
Cx43-mutant mice were significantly smaller than their wild type littermate controls. To
ensure that any changes in muscle size were not due to changes in overall bone structure,
tibial bone lengths were measured. I DOT and G60S Cx43-mutant mice did not show any
difference in bone length from their wild type littermates, despite the fact that G60S mice
are considerably smaller in size than their controls. Tibialis anterior (TA) and soleus
muscle fibre cross-sectional areas did not significantly differ in I DOT Cx43-mutant mice
compared to wild type littermates although data showed a trend towards mutant mice
exhibiting smaller TA muscle fibres. In the G60S mutant mouse, TA and soleus muscle
fibre cross-sectional areas were significantly smaller than those of wild type control
littermates. The reason why G60S mouse muscle fibre size differs from that of wild type
littermate controls and 1130T mouse muscle fibres may be due to the fact that these two
mutations are found in different locations on Cx43, or due to other unknown etiologies.
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3.2

Contributions of the Research
Oculodentodigital Dysplasia (ODDD) is a rare disease that manifests in a wide

range o f symptoms that differ in each patient (Laird, 2006). While the root of many
ODDD symptoms have been studied, the effect that the disease has, if any, on skeletal
muscle development is not known. Patients report loss of ambulatory control, general
muscle weakness, and weakness of the tibialis anterior muscle (Loddenkemper et al,
2002; & Paznekas et al., 2009) but there has not yet been a correlation between muscle
weakness and Cx43 mutations. Therefore, I investigated the possibility that these musclerelated symptoms are a result of impaired muscle development. Furthermore, this study
further characterized the dynamic relationship between Cx43 expression and myoblast
differentiation into myotubes. Finally, this is the first study to show that G60S and I130T
Cx43 mutants have a dominant-negative effect on gap junctional intercellular
communication in L6 myoblasts.

3.3

Limitations and Future Studies

3.3.1

Limitations of In Vitro Model

My studies were limited by difficulties encountered in transfecting cDNA
constructs into L6 myoblasts. Although others have used transfections to over-express
Cx43 in L6 myoblasts (Suzuki et al 2001), transfection with Lipofectamine and even
retroviral infection experiments using several different Cx43 vectors were unsuccessful in
the current study. While the use of the nucleofection technique was successful at
introducing Cx43 constructs into L6 myoblasts, these myoblasts did not differentiate, as
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they continued to divide, became confluent and died. Even wild type L6 myoblasts that
were put through the process of nucleofection without any inserted constructs failed to
properly differentiate. It is possible that these myoblasts do not adapt well to
manipulation and cannot function normally when put under stress. Another remote
possibility is that the media used to grow and differentiate the cells was no longer optimal
for nucleofector-stressed cells. Successful differentiation of myoblasts engineered to
express Cx43 mutants and appropriate control constructs would have provided key
insights into whether the co-expression of disease-linked mutants could disrupt myoblast
differentiation into myotubes.

3.3.2

Limitations of Pax7 Antibodies

Since satellite cells are known to play a role in postnatal muscle development and
repair, I wanted to examine a possible relationship between Cx43 and the number of
satellite cells per muscle fibre by studying the number of Pax7-positive satellite cells in
wild type and mutant mouse muscles. I hypothesized that mutant muscle would have less
Pax7-postive satellite cells. Fewer satellite cells might result in impaired postnatal muscle
development, which may explain the smaller fibres found in G60S mutant mouse muscle
and muscle weakness associated with ODDD patients. Unfortunately, after trying two
commercial Pax7 antibodies at different antibody concentrations, neither antibody
provided a consistent Pax7 nuclear signal. Pax7 staining seemed diffuse and non-specific
and often did not co-localize with Hoechst nuclear staining.
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3.3.3

Future Studies
Although I have identified Cx43 mutants as having a dominant negative effect on

co-expressed wild type Cx43 in L6 myoblasts, it is yet to be determined whether
myoblast differentiation itself is affected by the presence of Cx43 mutants. By
determining how well myoblasts expressing Cx43 mutants are able to differentiate
compared to wild type cells, 1 could determine if disease-linked Cx43 mutant expression
impairs L6 myoblast differentiation. The differentiation of myoblasts over-expressing
Cx43 and Cx43-mutants would also allow me to study the level of GJIC between
myotubes and individual myoblasts. Ultimately we need to further elucidate the role of
Cx43 GJIC in myoblast development as well as the mechanism of how Cx43 may be
regulated during differentiation.
In order to establish the connection between smaller muscle fibres and muscle
weakness, I could study the forelimb strengths of both mutant and wild type mice. One
would expect that impairment in muscle development may result in a loss of muscle
strength. A study by Martins-Silva et al (2011) used a grip force test on mice deficient for
the vesicular acetylcholine transporter. In this experiment, mice were held by their tails
and allowed to grip a bar connected to recording meter. Mice were pulled back
horizontally and the force applied to the bar at the time of release was recorded. This
approach could be used to analyze mutant mouse muscle strength compared to their wild
type littermates. Finally, in order to broaden the diversity in the in vivo portion of this
study it would be useful to include one-year-old mice as many of the muscle problems
associated with ODDD are found in older patients.

Another way to establish the role o f Cx43 and its mutants on skeletal muscle
development would be to examine muscle repair after injury. Adult skeletal muscle
development and repair both occur via satellite cell activation. One method of examining
muscle repair would be to injure the muscles of a Cx43 -mutant mouse and its wild type
littermate with the bupivacaine (Marcaine), known to cause severe muscle fiber damage
(Benoit and Belt, 1970). Marcaine-injected muscles from mutant and wild type mice at 3
weeks and 3 months of age could be tested for the presence of the satellite cell activation
marker Myf5 by western blotting. I expect that compared to wild type mice, mutant
mouse muscle would express less Myf5 expression due to presumably less satellite cells,
therefore exhibiting less muscle repair.
Finally, the collective evidence that Cx43 is critically involved in the early stages
of muscle development is quite convincing. Thus, I feel it still remains likely that ODDD
patients that are likely functioning on far less than a 50% complement of Cx43 function
will exhibit some deficiencies in skeletal muscle function or repair but further studies are
necessary to investigate this possibility.

\
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